1-4 of 4
Ryan M. Genga
Close
Sort by
Journal Articles

Investigation Into the Mechanism of Action and Binding Site of BAX 499, An Aptamer Against Tissue Factor Pathway Inhibitor

Emily K. Waters, PhD, Ryan M. Genga, Heather A. Thomson, Robert G. Schaub, PhD, Jeffrey C. Kurz, PhD, Kathleen E. McGinness, PhD
Journal: Blood
Blood (2011) 118 (21): 1214.
https://doi.org/10.1182/blood.V118.21.1214.1214
Published: 2011
Journal Articles

Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor

Emily K. Waters, Ryan M. Genga, Michael C. Schwartz, Jennifer A. Nelson, Robert G. Schaub, Karen A. Olson, Jeffrey C. Kurz, Kathleen E. McGinness
Journal: Blood
Blood (2011) 117 (20): 5514–5522.
https://doi.org/10.1182/blood-2010-10-311936
Published: 2011
Includes: Supplemental data
Journal Articles

Discovery and Characterization of An Anti-APC Aptamer for Use In Hemophilia

Patricia G.M. Wagner, Michael C. Schwartz, Kathleen E. McGinness, Ryan M. Genga, Jeffrey C. Kurz, PhD, Emily K. Waters, PhD, Robert Schaub, PhD
Journal: Blood
Blood (2010) 116 (21): 2222.
https://doi.org/10.1182/blood.V116.21.2222.2222
Published: 2010
Journal Articles

TFPI Antagonist Aptamer ARC19499 Is a Procoagulant In Vitro and In Vivo.

Kathleen E. McGinness, PhD, Emily K. Waters, PhD, Ryan M. Genga, Karen A. Olson, PhD, Jennifer A. Nelson, PhD, Jeffrey C. Kurz, PhD, Robert G. Schaub, PhD
Journal: Blood
Blood (2010) 116 (21): 1134.
https://doi.org/10.1182/blood.V116.21.1134.1134
Published: 2010